Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
SNYR 
Synergy CHC Corp. Common Stock (SNYR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: SNYR (3-star) is a STRONG-BUY. BUY since 6 days. Profits (-8.30%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
1 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Year Target Price $10
Year Target Price $10
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Under performing |
| 0 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 127.32% | Avg. Invested days 21 | Today’s Advisory Strong Buy |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 21.90M USD | Price to earnings Ratio 8.1 | 1Y Target Price 10 |
Price to earnings Ratio 8.1 | 1Y Target Price 10 | ||
Volume (30-day avg) - | Beta 0.69 | 52 Weeks Range 0.36 - 10.00 | Updated Date 06/29/2025 |
52 Weeks Range 0.36 - 10.00 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.3 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 7.21% | Operating Margin (TTM) 23.84% |
Management Effectiveness
Return on Assets (TTM) 26.73% | Return on Equity (TTM) -361.12% |
Valuation
Trailing PE 8.1 | Forward PE 5.09 | Enterprise Value 49980834 | Price to Sales(TTM) 0.65 |
Enterprise Value 49980834 | Price to Sales(TTM) 0.65 | ||
Enterprise Value to Revenue 1.49 | Enterprise Value to EBITDA 7.56 | Shares Outstanding 9014110 | Shares Floating 2654475 |
Shares Outstanding 9014110 | Shares Floating 2654475 | ||
Percent Insiders 69.93 | Percent Institutions 11.39 |
Analyst Ratings
Rating 4 | Target Price 10 | Buy 1 | Strong Buy - |
Buy 1 | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Synergy CHC Corp. Common Stock
Company Overview
History and Background
Synergy CHC Corp. was a consumer health company focused on acquiring and developing a diverse portfolio of consumer healthcare brands. It was founded with the aim of creating a stable and profitable business within the consumer health sector. The company has since been acquired.
Core Business Areas
- Consumer Healthcare Brands: Synergy CHC Corp. focused on over-the-counter (OTC) medications, vitamins, and supplements, and personal care products.
Leadership and Structure
Details on Synergy CHC Corp.'s specific leadership and organizational structure are not readily available, as the company is no longer publicly traded in its previous form.
Top Products and Market Share
Key Offerings
- BC Powder: BC Powder is an over-the-counter pain reliever. Market share information is not readily available. Competitors include Bayer (BAYRY), GSK (GSK), and Johnson & Johnson (JNJ).
- Alka-Seltzer Plus: Alka-Seltzer Plus offers cold and flu relief. Market share information is not readily available. Key competitors include Theraflu (BAYRY) and Vicks (PG).
Market Dynamics
Industry Overview
The consumer healthcare industry is characterized by steady growth, driven by increasing health awareness, aging populations, and a shift towards self-medication. It is a highly competitive market with established players and emerging brands.
Positioning
Synergy CHC Corp. aimed to carve out a niche by acquiring established brands with potential for revitalization and expansion. Its competitive advantage lay in its ability to leverage marketing and distribution channels effectively.
Total Addressable Market (TAM)
The total addressable market for the consumer healthcare sector is vast, estimated to be hundreds of billions of dollars globally. Synergy CHC Corp. aimed to capture a small but significant share of this market through its targeted brand portfolio.
Upturn SWOT Analysis
Strengths
- Established brands
- Diverse product portfolio
- Effective marketing strategies
- Distribution network
Weaknesses
- Dependence on acquired brands
- Limited innovation in-house
- Vulnerability to changing consumer preferences
- High marketing costs
Opportunities
- Expansion into new geographic markets
- Development of new products and formulations
- Acquisition of complementary brands
- Leveraging e-commerce channels
Threats
- Increased competition from larger players
- Regulatory changes
- Changing consumer preferences
- Economic downturns
Competitors and Market Share
Key Competitors
- PG
- JNJ
- BAYRY
- GSK
Competitive Landscape
Synergy CHC Corp. faced intense competition from larger, more established players with greater resources. Its advantage lay in its focused portfolio and ability to revitalize acquired brands.
Growth Trajectory and Initiatives
Historical Growth: Synergy CHC Corp.'s historical growth was driven by acquisitions and organic growth of its portfolio brands.
Future Projections: Future projections are not available as they are not a public traded company.
Recent Initiatives: Recent initiatives involved brand revitalization and expansion into new markets. More specific information is unavailable.
Summary
Synergy CHC Corp. operated in the competitive consumer healthcare market by acquiring and managing established brands. Its success depended on effective brand management and strategic acquisitions. The company's challenges included intense competition and vulnerability to changing consumer preferences. As a now private entity, past performance is not indicative of future success in a different structure.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Public reports, Market research reports, Industry analysis
Disclaimers:
The information provided is based on available public data and may not be entirely comprehensive. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Synergy CHC Corp. Common Stock
Exchange NASDAQ | Headquaters Westbrook, ME, United States | ||
IPO Launch date 2016-01-04 | CEO & Chairman Mr. Jack Ross | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 21 | Website https://synergychc.com |
Full time employees 21 | Website https://synergychc.com | ||
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; and lifestyle and wellness products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name. The company also provides hand care products under the Hand MD brand name; beauty products for the eyes, lips, brows, cheeks, and skin under the Perfekt Beauty brand; shapewear, bralettes, and panties under Sneaky Vaunt brand; eyelash enhancement products under The Queen Pegasus brand; topical treatments for neuropathic pain under Neuragen brand; and over-the-counter medications under UrgentRx brand. It sells its products through club, mass drug, and other retailers. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. The company was incorporated in 2010 and is based in Westbrook, Maine.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.